UK Markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,429.00+9.00 (+0.63%)
At close: 06:00PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32,746.59
52-week low 31,280.92
50-day moving average 31,434.20
200-day moving average 31,461.71

Share statistics

Avg vol (3-month) 310.1M
Avg vol (10-day) 36.54M
Shares outstanding 54.09B
Implied shares outstanding 6N/A
Float 83.9B
% held by insiders 10.69%
% held by institutions 141.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.61
Forward annual dividend yield 44.08%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.06%
5-year average dividend yield 45.30
Payout ratio 469.83%
Dividend date 3N/A
Ex-dividend date 423 Feb 2023
Last split factor 22:1
Last split date 328 Oct 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 51.00%
Operating margin (ttm)25.04%

Management effectiveness

Return on assets (ttm)6.59%
Return on equity (ttm)31.31%

Income statement

Revenue (ttm)29.32B
Revenue per share (ttm)7.28
Quarterly revenue growth (yoy)-22.60%
Gross profit (ttm)19.92B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)104.20
Quarterly earnings growth (yoy)99.60%

Balance sheet

Total cash (mrq)7.88B
Total cash per share (mrq)1.95
Total debt (mrq)20.99B
Total debt/equity (mrq)207.87
Current ratio (mrq)0.91
Book value per share (mrq)2.97

Cash flow statement

Operating cash flow (ttm)7.4B
Levered free cash flow (ttm)3.59B